Company news
Shanghai Yizhong Pharmaceutical Co. Ltd. Class A (SSE:688091) news
Shanghai Yizhong Pharmaceutical Co. Ltd. Class A news releases on 6ix. Latest, Mar 26, 2025: Indicative Announcement on Equity Change of Shareholders Reaching…
Press releases — page 2
Indicative Announcement on Equity Change of Shareholders Reaching an Integral Multiple of 1%
March 25, 2025
Announcement of the Vesting Results and Stock Listing for the Reserved Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period
March 7, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on the Resignation of Non-independent Director
January 17, 2025
Announcement on Implementation Result of Repurchasing Shares and Share Changes
December 26, 2024
Announcement of the Vesting Results and Stock Listing for the First Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period
December 16, 2024
Announcement on Convening the Q3 2024 Performance Briefing
December 10, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
December 3, 2024
Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance
November 28, 2024
Announcement on Resolution of the 8th Meeting of the 2nd Board of Directors
November 26, 2024
Announcement on Resolution of the 7th Meeting of the 2nd Board of Supervisors
October 28, 2024
Announcement on Obtaining Notice of Approval for Drug Clinical Trials
October 15, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
October 9, 2024